Ontario’s plunging price-caps on generics: deeper dives may drown some drugs
نویسندگان
چکیده
In April 2010, the Ontario government announced another reduction in the maximum price of generic drugs permitted under the Ontario Drug Benefit (ODB) program, demanding that generic drugs now be sold for no more than 25% of the branded product's price. Other provinces are following Ontario in setting unprecedentedly low price-caps to reduce the cost of generic drugs. Generic product substitution legislation is vital to reducing costs to provincial drug plans, yet lower and lower price-caps may undo some of the benefits of substitution legislation if generics find it difficult to survive.
منابع مشابه
Pursuit plunging by northern gannets (Sula bassana) feeding on capelin (Mallotus villosus).
Northern gannets (Sula bassana) are considered to obtain prey usually by rapid, vertical, shallow plunge dives. In order to test this contention and investigate underwater foraging behaviour, we attached two types of data-logging systems to 11 parental northern gannets at Funk Island in the North-Wiest Atlantic. We documented, for the first time to the authors' knowledge, gannets performing lon...
متن کاملA New Pharmaceutical Environment in Iran: Marketing Impacts
For nearly 25 years, Iranian Pharmaceutical market has been a closed and centrally controlled one. Although some initiatives have been introduced during the last decade, yet the system is characterized as a closed one and lacks real competition. The current situation of drug in Iran may be characterized as: Intense price control by the Drug Authority i.e. Ministry of Health Ban of d...
متن کاملA New Pharmaceutical Environment in Iran: Marketing Impacts
For nearly 25 years, Iranian Pharmaceutical market has been a closed and centrally controlled one. Although some initiatives have been introduced during the last decade, yet the system is characterized as a closed one and lacks real competition. The current situation of drug in Iran may be characterized as: Intense price control by the Drug Authority i.e. Ministry of Health Ban of d...
متن کامل[Reimbursement of generics in Croatia: should more have been done?].
BACKGROUND while numerous ordinances on drug pricing and reimbursement have been enacted, trying to suppress the drug expenditure in Croatia, it seemed there were inconsistencies in pricing procedures of some of the drugs. OBJECTIVES to show whether or not the pricing system given has had the desired result, we review pricing and reimbursement systems of generics in some of the EU countries a...
متن کاملA price and use comparison of generic versus originator cardiovascular medicines: a hospital study in Chongqing, China
BACKGROUND Developed countries use generic competition to contain pharmaceutical expenditure. China, as a developing and transitional country, has not yet deemed an increase in the use of generic products as important; otherwise, much effort has been made to decrease the drug prices. This paper aims to explore dynamically the price and use comparison of generic and originator drugs in China, an...
متن کامل